Is a 'predictable' and 'manageable' phase of COVID finally upon us?
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
You are now subscribed
Your newsletter sign-up was successful
While the COVID-19 pandemic (unfortunately) has yet to come to an end, America may be entering a new phase of the crisis, Axios argues, "one in which the country's overall experience with this virus will be less like having a heart attack, and more like managing a lifelong chronic condition."
In some ways, the transition to "endemic" COVID – meaning the virus will become a "predictable, manageable" part of our lives — is already here, Axios says, positing that though the disease is here to stay, the "worst of the pandemic is likely behind us."
The U.S. is, at the moment, averaging about 74,000 new infections daily, a "4 percent increase of the past two weeks," per Axios. And when analyzing individual states, only 4 would qualify as having a low rate of transmission according to CDC guidelines.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Despite that, former FDA Commissioner Scott Gottlieb said recently that "we're close to the end of the pandemic phase of the virus," though former White House COVID adviser Andy Slavitt disagreed and called for an end to the speculation.
But here's the rub — the end of COVID's "pandemic phase" won't mean the end of COVID infections. There will still be breakthrough cases (though less severe) and winter outbreaks (though hopefully not as big or as deadly as before).
And the framework for this state of play, Axios argues, has already arrived. So, as long as "no new variant emerges," (which is of course possible, but not yet an immediate threat), "we have a pretty good idea of where we're headed, and that overall landscape isn't likely to change too dramatically." Read more at Axios.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.
-
5 cinematic cartoons about Bezos betting big on 'Melania'Cartoons Artists take on a girlboss, a fetching newspaper, and more
-
The fall of the generals: China’s military purgeIn the Spotlight Xi Jinping’s extraordinary removal of senior general proves that no-one is safe from anti-corruption drive that has investigated millions
-
Why the Gorton and Denton by-election is a ‘Frankenstein’s monster’Talking Point Reform and the Greens have the Labour seat in their sights, but the constituency’s complex demographics make messaging tricky
-
A Nipah virus outbreak in India has brought back Covid-era surveillanceUnder the radar The disease can spread through animals and humans
-
Trump HHS slashes advised child vaccinationsSpeed Read In a widely condemned move, the CDC will now recommend that children get vaccinated against 11 communicable diseases, not 17
-
Covid-19 mRNA vaccines could help fight cancerUnder the radar They boost the immune system
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
